Clinical Trial Update: Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients [Phase 4]

View source ↗

Summary

A Phase 4 tolerability study of vigabatrin (Sabril) for complex partial seizures was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Partial Seizures
• Temporal Lobe Epilepsy

Drugs mentioned

• SABRIL (VIGABATRIN)

Snippet

Sponsor: University of Pennsylvania | Conditions: Complex Partial Seizures | Phase 4 | Status: TERMINATED | Results posted: 2017-07-12